ISSN: 1471-4892

Journal Home

Journal Guideline

Current Opinion in Pharmacology Q1 Unclaimed

Elsevier BV Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Pharmacology is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 127. It has an SJR impact factor of 1,989 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q1) Pharmacology (Q1)

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

1,989

SJR Impact factor

127

H Index

113

Total Docs (Last Year)

338

Total Docs (3 years)

6463

Total Refs

1611

Total Cites (3 years)

303

Citable Docs (3 years)

5

Cites/Doc (2 years)

57,19

Ref/Doc

Aims and Scope

Other journals with similar parameters

Nature Reviews Drug Discovery Q1
Perspectives in Medicinal Chemistry Q1
Molecular Therapy Q1
Natural Product Reports Q1
Cell Chemical Biology Q1

Best articles

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer

A new era for gastrointestinal research - novel therapeutic targets for drug development

Acid-sensitive ion channels in gastrointestinal function

Adult growth hormone replacement: current understanding

Anti-infective challenges in the 21st century: from superbugs to viral pandemics

Anti-infectives

Anti-infectives New technologies

Anti-infectives: New technologies

Anti-inflammatory therapy for heart failure

Applications of microarrays in the pharmaceutical industry

beta-Lactamase-inhibitor combinations in the 21st century: current agents and new developments

Calcium channels in enteric neurons

SHOW MORE ARTICLES

Cancer Immunomodulation

Cellular screening assays using fluorescence microscopy

CFTR pharmacology and its role in intestinal fluid secretion

Changes and challenges - the world post-Gleevec‚Ñ¢ (Glivec¬Æ)

Clinical uses and misuses of dehydroepiandrosterone

Conductances responsible for slow wave generation and propagation in interstitial cells of Cajal

Cotransmission

Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs

Cyclooxygenase-2 and inflammation in atherosclerosis

Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development

Drug inhibition of angiogenesis

Drug transport via the intestinal peptide transporter PepT1

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.